Related Experiment Video
Updated: Sep 4, 2025

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
"Papillary Adenoma-like" Renal Tumor with TFE3 Gene Rearrangement, A Potential Precursor to or Early Event in the
Khalid Algarrahi1, Evanthia Omoscharka2, Ming Zhou1
1Department of Pathology & Laboratory Medicine, Tufts Medical Center, Boston, MA, USA.
Abstract:
MiT family translocation renal cell carcinomas harbor gene fusion involving members of MiT family of transcription factors. Their precursor lesions have not been identified. Herein, we report the first case of small papillary tumors morphologically resembling papillary adenomas but harboring TFE3 gene alteration. The patient was a 23-year old man with multiple small papillary tumors in the right kidney discovered following a gunshot wound injury. These lesions were < 5 mm, well-circumscribed but not encapsulated tubulopapillary proliferation lined with a single layer of cuboidal cells with WHO/ISUP grade 1 or 2 nuclei. The tumor cells were immunoreactive to PAX8, AMACR, high molecular weight cytokeratin, and keratin 7 and negative for CD10, CA9, TTF1, and cathepsin K. Morphologically and immunohistochemically, these lesions were diagnosed as papillary adenomas. TFE3 gene rearrangement was confirmed by fluorescence in-situ hybridization (FISH) using a TFE3 break-apart probe. We term these tumors "papillary adenoma-like" renal tumor with TFE3 gene rearrangement. These tumors are likely a precursor to or represent an early event in the development of TFE3 translocation renal cell carcinomas. An understanding of such tumors to translocation renal cell carcinoma progression can provide insight into the pathogenic mechanism, and ultimately aid the diagnosis and management of translocation renal cell carcinoma.
Insights
Researchers identified novel "papillary adenoma-like" renal tumors with TFE3 gene alterations. These small tumors may represent an early stage in the development of TFE3 translocation renal cell carcinoma.
Area of Science:
- Oncology
- Genetics
- Pathology
Background:
- MiT family translocation renal cell carcinomas (RCCs) are defined by gene fusions involving MiT family transcription factors.
- The precursor lesions for these aggressive RCCs remain unidentified, hindering our understanding of their development.
Observation:
- A case study of a 23-year-old male revealed multiple small, <5mm papillary renal tumors.
- These lesions exhibited features of papillary adenomas but harbored a TFE3 gene rearrangement, confirmed by fluorescence in-situ hybridization (FISH).
- Immunohistochemical analysis showed tumor cells were positive for PAX8, AMACR, high molecular weight cytokeratin, and keratin 7, but negative for CD10, CA9, TTF1, and cathepsin K.
Findings:
- The small papillary tumors were morphologically and immunohistochemically diagnosed as papillary adenomas.
- Crucially, these lesions demonstrated TFE3 gene rearrangement, a hallmark of MiT family translocation RCCs.
Implications:
- These "papillary adenoma-like" tumors with TFE3 rearrangement are proposed as potential precursors or early events in the pathogenesis of TFE3 translocation RCC.
- Understanding these precursor lesions can offer insights into RCC development and aid in the diagnosis and management of translocation RCCs.
More Related Videos
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

